Citation Impact
Citing Papers
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Genetic Influences on Brain Gene Expression in Rats Selected for Tameness and Aggression
2014 StandoutNobel
Deep Brain Stimulation for Treatment-Resistant Depression
2005 Standout
Lithium’s Emerging Role in the Treatment of Refractory Major Depressive Episodes: Augmentation of Antidepressants
2010
Sleep and mental disorders: A meta-analysis of polysomnographic research.
2016
A Meta-Analysis of Cytokines in Major Depression
2009 Standout
Clinical and Neurobiological Effects of Tianeptine and Paroxetine in Major Depression
2003
The Dexamethasone/Corticotropin-Releasing Factor Test in Men with Major Depression: Role of Childhood Trauma
2007
Major depressive disorder is a risk factor for low bone mass, central obesity, and other medical conditions
2011
Molecular studies of major depressive disorder: the epigenetic perspective
2007
Depression
2018 Standout
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Imaging phenotypes of major depressive disorder: genetic correlates
2009
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
2009 Standout
Different responses to dexamethasone and prednisolone in the same depressed patients
2006
Metyrapone as Additive Treatment in Major Depression
2004
The Corticosteroid Receptor Hypothesis of Depression
2000 Standout
Low Cortisol and Risk for PTSD in Adult Offspring of Holocaust Survivors
2000
Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse
2009 Standout
Is burnout separable from depression in cluster analysis? A longitudinal study
2014
Perceived discrimination and health: A meta-analytic review.
2009 Standout
Cytokines and depression
2002
(Far) Outside the box: Genomic approach to acute porphyria
2006
Neural regulation of endocrine and autonomic stress responses
2009 Standout
Novel Drugs and Therapeutic Targets for Severe Mood Disorders
2008
Overexpressing the Glucocorticoid Receptor in Forebrain Causes an Aging-Like Neuroendocrine Phenotype and Mild Cognitive Dysfunction
2007
Cognitive and serotonergic vulnerability to depression: Convergent findings.
2007
Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain
2007 Standout
The link between childhood trauma and depression: Insights from HPA axis studies in humans
2008
The Lifelong Effects of Early Childhood Adversity and Toxic Stress
2011 Standout
Genetics of sleep and sleep disorders
2007
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
2012
Glucocorticoid Dysregulations and Their Clinical Correlates
2009
Effects of stress throughout the lifespan on the brain, behaviour and cognition
2009 Standout
Bipolar and major depressive disorder: Neuroimaging the developmental-degenerative divide
2009
Effect of early life stress on serotonin responses in the hippocampus of young adult rats
2004
Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms?
2001
Porphyrias
2010 Standout
Younger, premenopausal women with major depressive disorder have more abdominal fat and increased serum levels of prothrombotic factors: implications for greater cardiovascular risk
2005
Improvements in Neurocognitive Function and Mood Following Adjunctive Treatment with Mifepristone (RU-486) in Bipolar Disorder
2004
Dysregulated relationship of inflammation and oxidative stress in major depression
2012
Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association
2022 Standout
Restoring melancholia in the classification of mood disorders
2007
When Not Enough Is Too Much: The Role of Insufficient Glucocorticoid Signaling in the Pathophysiology of Stress-Related Disorders
2003
Mice with Mutations in the HPA-System as Models for Symptoms of Depression
2006
Increase in Concentration of Waking Salivary Cortisol in Recovered Patients With Depression
2003
Linking “big” personality traits to anxiety, depressive, and substance use disorders: A meta-analysis.
2010 Standout
Post-Traumatic Stress Disorder
2002
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research
2009 Standout
Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse
2002
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
2001
Thymopoiesis, Regulatory T Cells, and TCRVβ Expression in Thymoma With and Without Myasthenia Gravis, and Modulatory Effects of Steroid Therapy
2007
The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
1999
Increased telomerase activity and comprehensive lifestyle changes: a pilot study
2008 StandoutNobel
Schizophrenia: a purinergic hypothesis
2000
Gut–brain axis: how the microbiome influences anxiety and depression
2013 Standout
??-1 Receptor Ligands
2004
Stress and the brain: from adaptation to disease
2005 Standout
Genetic pathway of major depressive disorder in shortening telomeric length
2007
Timing of Pubertal Maturation in Girls: An Integrated Life History Approach.
2004 Standout
Power failure: why small sample size undermines the reliability of neuroscience
2013 Standout
Overnight emotional adaptation to negative stimuli is altered by REM sleep deprivation and is correlated with intervening dream emotions
2009
The SIGMAR1 gene is associated with a risk of schizophrenia and activation of the prefrontal cortex
2011
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Neurobiology of Depression
2002 Standout
Pharmacogenetics of Antidepressants
2011
Discovering Endophenotypes for Major Depression
2004
The Mesolimbic Dopamine Reward Circuit in Depression
2006 Standout
Differential modulation of cytokine production in major depressive disorder by cortisol and dexamethasone
2008
Sex differences in the adult HPA axis and affective behaviors are altered by perinatal exposure to a low dose of bisphenol A
2014
The HPA axis in major depression: classical theories and new developments
2008 Standout
Burnout and physical and mental health among Swedish healthcare workers
2008
Strength and vulnerability integration: A model of emotional well-being across adulthood.
2010 Standout
The stress system in the human brain in depression and neurodegeneration
2005
Corticotropin-releasing hormone in depression and post-traumatic stress disorder
2001
Major Depressive Disorder
2008 Standout
Hypothalamo‐Pituitary‐Adrenal Axis and Chronic Immune Activation
2003
FOXP3+ regulatory T cells in the human immune system
2010 StandoutNobel
Meta-analyses of genetic studies on major depressive disorder
2007
State and trait influences on mood regulation in bipolar disorder: blood flow differences with an acute mood challenge
2003
The co-morbidity of anxiety and depression in the perspective of genetic epidemiology. A review of twin and family studies
2005
Cognitive Impairment in Major Depression: Association with Salivary Cortisol
2009
Long-term behavioral and neuroendocrine adaptations to adverse early experience
2000
Successful Antidepressant Therapy Restores the Disturbed Interplay Between TNF-α System and HPA Axis
2006
Do personality traits predict first onset in depressive and bipolar disorder?
2006
The hypothalamic–pituitary–adrenal axis and sex hormones in chronic stress and obesity: pathophysiological and clinical aspects
2012
How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials
2008
Association of Torture and Other Potentially Traumatic Events With Mental Health Outcomes Among Populations Exposed to Mass Conflict and Displacement
2009 Standout
Glucocorticoid antagonists in neuropsychotic disorders
2008
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic
2007 Standout
From inflammation to sickness and depression: when the immune system subjugates the brain
2007 Standout
Effects of the monoamine oxidase A inhibitor moclobemide on hippocampal plasticity in GR-impaired transgenic mice
2001
If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans.
2007 Standout
Approaching the shared biology of obesity and depression: the stress axis as the locus of gene–environment interactions
2006
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
The molecular neurobiology of depression
2008 StandoutNature
The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies
2001 Standout
Neuroscience, Molecular Biology, and the Childhood Roots of Health Disparities
2009 Standout
Vasopressin Mediates the Response of the Combined Dexamethasone/CRH Test in Hyper-anxious Rats Implications for Pathogenesis of Affective Disorders
2002
A Genome-Wide Association Study of Neuroticism in a Population-Based Sample
2010
A meta-analysis of cortisol response to challenge in human aging: importance of gender
2004
The role of inflammation in depression: from evolutionary imperative to modern treatment target
2015 Standout
Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival
2007 Standout
Can Meditation Slow Rate of Cellular Aging? Cognitive Stress, Mindfulness, and Telomeres
2009 StandoutNobel
Cytokine-effects on glucocorticoid receptor function: Relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression
2006
Long-term exposure to high corticosterone levels attenuates serotonin responses in rat hippocampal CA1 neurons
1999
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
The Job Demands‐Resources model: state of the art
2007 Standout
Prevalence of Burnout Among Physicians
2018 Standout
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Heritability of Sleep Electroencephalogram
2008
The circadian basis of winter depression
2006
Stress, hypercortisolism and corticosteroid receptors in depression: implicatons for therapy
2001
Is burnout solely job‐related? A critical comment
2014
Perphenazine for schizophrenia
2015
About Sleep's Role in Memory
2013 Standout
Stress Hormone Regulation: Biological Role and Translation into Therapy
2009
Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior
2004
Life Events, Stress and Depression: A Review of Recent Findings
2002
Works of S. Modell being referenced
The Munich vulnerability study on affective disorders: microstructure of sleep in high-risk subjects
2008
Neuroendocrine, Cognitive and Structural Imaging Characteristics of Women on Longterm Sickleave with Job Stress–Induced Depression
2006
Neuroendocrine, polysomnographic and psychometric observations in healthy subjects at high familial risk for affective disorders: the current state of the ‘Munich vulnerability study’
2001
Die Münchner Vulnerabilitäts-Studie zu affektiven Erkrankungen
1998
Polymorphisms of the Glucocorticoid Receptor Gene and Major Depression
2006
Elevated response of growth hormone to graded doses of apomorphine in schizophrenic patients
1998
Pharmacological and Nonpharmacological Factors Influencing Hypothalamic–Pituitary–Adrenocortical Axis Reactivity in Acutely Depressed Psychiatric In-patients, Measured by the Dex-CRH Test
2003
The Munich Vulnerability Study on Affective Disorders: risk factors for unipolarity versus bipolarity
2003
The Munich vulnerability study on affective disorders: stability of polysomnographic findings over time
2002
The combined dexamethasone/CRH test as a potential surrogate marker in depression
2005
Switching to Aripiprazole in Outpatients with Schizophrenia Experiencing Insufficient Efficacy and/or Safety/Tolerability Issues with Risperidone: A Randomized, Multicentre, Open-label Study
2009
The Munich vulnerability study on affective disorders: overview of the cross-sectional observations at index investigation
1998
Corticosteroid Receptor Function Is Decreased in Depressed Patients
1997
Association between response to lithium augmentation and the combined DEX/CRH test in major depressive disorder
2003
The Munich Vulnerability Study on Affective Disorders: Premorbid Polysomnographic Profile of Affected High-Risk Probands
2005
The pre-morbid psychometric profile is stable over time in subjects at high familial risk for affective disorders
1998
Suppressed Neuroendocrine Stress Response in Depressed Women on Job-Stress-Related Long-Term Sick Leave: A Stable Marker Potentially Suggestive of Preexisting Vulnerability
2008
Blunted ACTH response to dexamethasone suppression-CRH stimulation in posttraumatic stress disorder
2008
The Munich vulnerability study on affective disorders: premorbid psychometric profile of affected individuals
2004
Hormonal Response Pattern in the Combined DEX-CRH Test Is Stable over Time in Subjects at High Familial Risk for Affective Disorders
1998
Impaired divided attention predicts delayed response and risk to relapse in subjects with depressive disorders
2004
Efficacy and Safety of an Opiate Sigma-Receptor Antagonist (SL 82.0715) in Schizophrenic Patients with Negative Symptoms: an Open Dose-Range Study
1996
Efficacy and safety of lower doses of aripiprazole
2005
P.2.076 Efficacy of aripiprazole and perphenazine in severe schizophrenia resistant to treatment with atypical antipsychotics
2004